SCHEMBL3215316

SCHEMBL3215316

Cc1ccccc1NN=C(CC1=C(C(C)(C)C)C=CC1)c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.34
ALDH1A1 P00352 7/20 0.34
TDP1 Q9NUW8 7/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 4/20 0.33
RAB9A P51151 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 3/20 0.33
PTBP1 P26599 1/20 0.33
GAA P10253 6/20 0.32
KDM4E B2RXH2 3/20 0.32
LMNA P02545 2/20 0.32
MAPK1 P28482 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
THRB P10828 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 4/20 0.32
MEN1 O00255 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3214903 0.87 ALDH1A1 (0.43) MAPTALDH1A1TDP1SMN1; SMN2HPGD
SCHEMBL3191811 0.85 MAPT (0.37) MAPTALDH1A1TDP1SMN1; SMN2PKM
SCHEMBL3199281 0.85 KMT2A (0.34) MAPTALDH1A1TDP1SMN1; SMN2HPGD
SCHEMBL3214866 0.83 CTSL (0.33) MAPTALDH1A1TDP1SMN1; SMN2HPGD
SCHEMBL3208187 0.82 KMT2A (0.38) MAPTALDH1A1TDP1SMN1; SMN2HTT
SCHEMBL3215674 0.81 MAPT (0.36) MAPTALDH1A1TDP1SMN1; SMN2PKM
SCHEMBL3199127 0.80 APEX1 (0.38) MAPTALDH1A1TDP1SMN1; SMN2HPGD
SCHEMBL3193444 0.77 LMNA (0.36) ALDH1A1SMN1; SMN2RAB9AHTTLMNA
SCHEMBL3213949 0.76 MAPT (0.37) MAPTALDH1A1TDP1SMN1; SMN2PKM
SCHEMBL3214936 0.75 MAPT (0.38) MAPTALDH1A1TDP1SMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732643-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-08 US disclosed
US-7671226-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-02 US disclosed
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME HANAOKA HIDENORI 2010-02-25 US disclosed
EP-1426379-B1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME SUMITOMO CHEMICAL CO (JP) 2009-11-11 EP disclosed
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same HANAOKA HIDENORI 2009-02-26 US disclosed
US-7439379-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-20040242410-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-02 US disclosed
EP-1426379-A1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same C1R, C1S, AP1M1 MAPT 2641/4885ALDH1A1 1229/4885TDP1 4304/4885
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME C1R, C1S, AP1M1 MAPT 2641/4885ALDH1A1 1229/4885TDP1 4304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.